Macomics Limited

Macrophage biology revealed.

[Macomics Limited @MacomicsL]

Less than a week to go to vote for Macomics in the @OneNucleus #BioNewsRound #awards 2023 for the news of our deal with @Ono_Pharma_pr - voting is just one click away https://t.co/8sTNFxuGAI

[Macomics Limited @MacomicsL]

We are thrilled to be shortlisted in this year's BioNewsRound awards. Voting is now open - click here https://t.co/EuBFMcwsIk

[Macomics Limited @MacomicsL]

Delighted to announce that Macomics has been seleted as a finalist for the ON Helix BioNewsRound Award 2023

https://t.co/JQc5PghDlo

[Macomics Limited @MacomicsL]

Passionate about developing novel therapies targeting tumour-associated macrophages, he leaves a huge legacy to the cancer research community and to the world of macrophage biology.

[Macomics Limited @MacomicsL]

With great sadness we announce the passing of our Founder, Director and Adviser, Professor Jeff W. Pollard, on 1 May 2023. He died peacefully at home after struggling against cancer.

[Macomics Limited @MacomicsL]

Our Co-Founder and VP Immunology, @CassettaLuca is speaking at #ImmunoUK by @OGConferences on 28-29 March. Luca will share our precision medicine approach which modulates #macrophage biology as an innovative #cancer treatment.
Find out more: https://t.co/ed5mrteVUK

[Macomics Limited @MacomicsL]

Congratulations to our talented runners Alicia Poindron, Chantell Payton, Amber Ngo, Moritz Haneklaus, and Krzysztof Wicher who completed the #Cambridge Chariots of Fire run this weekend in aid of Arthur Rank Hospice👏 🥳
Donate here https://t.co/CDSOxx9Q5r

[Macomics Limited @MacomicsL]

Summer is over, conference season is here. We’ll be attending a number of business & scientific conferences in the coming months: read full list here https://t.co/SBR17GqFcU.

Reach out if you’d like to meet us for an update on our progress #macrophage #drugdiscovery #Immunology

[Macomics Limited @MacomicsL]

Lisa Seymour (AIOSH) joins from Sanger Institute bringing 18 years experience in technical and admin roles. A graduate from Cambridge University, Member of IOSH & the Royal Society of Biology with NEBOSH general Certificate in Occupational Health & Safety.

[Macomics Limited @MacomicsL]

We are delighted to welcome 3 new team member to our #Cambridgeshire and #Edinburgh sites. In our R&D team, Dr Thomas Crozier joins as a Senior Scientist & Dr Yuxin Cui as Senior Bioinformatician. Ms. Lisa Seymour joining as Operations Manager and Health & Safety Officer.

[Macomics Limited @MacomicsL]

Dr Cui specialises in bioinformatic analysis of large-scale multi-omics data. He is building our bioinformatic engine to deepen our understanding of biology of human macrophages. Past experience Apitope, Cardiff University, the University of Cambridge, University of Bristol.

[Macomics Limited @MacomicsL]

Our co-founder Prof. Jeffery Pollard has been named on the annual Highly Cited Researchers™ 2021 list from @ClarivateAG. His ground-breaking research demonstrates the role of #macrophages in disease.
#congratulations #HighlyCited2021 #immunotherapy #cancer

[Macomics Limited @MacomicsL]

#Congratulations - our co-founder and VP Immunology, Dr @CassettaLuca has been honoured with the @sitcancer ‘Best Immunotherapy Biomarkers Paper Award’ for this publication https://t.co/SAisV3Lzx9
#SITC21 #Immunotherapy #Cancer

[Macomics Limited @MacomicsL]

Our Co-Founder and VP Immunology, @CassettaLuca will be presenting at the ImmunoUK: In person by @OGConferences on #macrophage biology. We’re delighted to be able to present in person once again.
To find out more about the event: https://t.co/dcpxCbNITE

[Macomics Limited @MacomicsL]

Welcome to our new R&D team members #MoritzHaneklaus #CarmenRodriguezSeoane #ChantellPayton #ConorPoland #SadieKemp.
Full release here (https://t.co/FOqQbdQHLO).
#lifesciences #oncology #cancer #drugdiscovery #appointment #expansion #Cambridge #macrophage #Edinburgh

[Macomics Limited @MacomicsL]

Our leadership team is expanded with the appointment of Carola Ries who joins as Chief Scientific Officer after 16 years at @Roche, to lead our macrophage-based therapeutics R&D. Welcome.
Full release including our £4.24m follow-on financing (https://t.co/6K3O7i9676).

[Macomics Limited @MacomicsL]

Pleased to announce £4.24m follow-on financing. Existing investors Epidarex Capital, who led the round, & Scottish Enterprise, & new investor Caribou Property Limited @ElizabethRoper
Full release here (https://t.co/6K3O7i9676). #Edinburgh #Cambridge #drugdiscovery #Biotechnology